NOS2 and early-onset autosomal dominant Alzheimer disease: For example, it has been reported that OC targeted different inflammation mediators, such as COXs [14] and inducible nitric oxide synthase (iNOS) [15], whereas in an Alzheimer’s disease model, OC protected neurons by inhibiting tau fibrillation [16].